Home > Animal Health & Nutrition > Veterinary Medical Devices > Veterinary Injectable Devices Market

Veterinary Injectable Devices Market Share

Report ID: GMI6053
Published Date: Jun 2023
Report Format: PDF

Download Free Sample

Veterinary Injectable Devices Market Share

Some of the major market players operating in the veterinary injectable devices market are

Merck & Co., Inc.
Hamilton Company
Neogen Corporation
Micrel Medical Devices SA
Serumwerk Bernburg AG
PBS Animal Health
Medtronic plc
Millpledge Pharmaceuticals
Terumo Medical Corporation
and Baxter International Inc.

Authors: Mariam Faizullabhoy, Gauri Wani

Frequently Asked Questions (FAQ) :

Global market for veterinary injectable devices was worth USD 879.1 million in 2022 and is expected to reach USD 1,418.3 million by 2032 driven by the increasing demand for veterinary healthcare and the rising need for disease prevention and management.

The syringes product segment held 29.3% share in the market and is estimated to depict significant growth through 2032 owing to the rising trend of pet ownership and the growing awareness of animal health.

North America industry is poised to grow at 4.7% CAGR from 2023 to 2032 attributed to the presence of well-developed veterinary infrastructure, including veterinary practices, hospitals, and clinics across the region.

Merck & Co., Inc., Hamilton Company, Neogen Corporation, Micrel Medical Devices SA, Serumwerk Bernburg AG, PBS Animal Health, Medtronic plc, Millpledge Pharmaceuticals, Terumo Medical Corporation, and Baxter International Inc. are among the top participants in the industry.